Home
Conditions
Leukemia, Hairy Cell

Clinical trial condition

Leukemia, Hairy Cell

Explore clinical trials studying Leukemia, Hairy Cell. Study availability and eligibility vary by location and protocol.

170 public trials 16 recruiting studies

Refine in advanced search Browse all conditions

Leukemia, Hairy Cell trial results

Recruiting

AutologousCD22 Chimeric Antigen Receptor (CAR)T Cells in w/Recurrent/Refractory B Cell Lymphomas

NCT06340737

Conditions: Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +38 more
Locations: Stanford University Palo Alto, California, United States

View Trial Details

Recruiting

3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer

NCT00935090

Conditions: Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +101 more
Locations: Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States

View Trial Details

Recruiting

Assessment of Disease Burden in Hairy Cell Leukemia

NCT06781515

Conditions: Hairy Cell Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +8 more
Locations: IRCCS Azienda Ospedaliero - Universitaria di Bologna Bologna, Italy

View Trial Details

Recruiting

Decoding the Extracellular Vesicles-driven Communication in the Microenvironment of Hairy Cell Leukemia to Improve Patient Care Management

NCT06774677

Conditions: Hairy Cell Leukemia (HCL), Hematologic Diseases, Hemic and Lymphatic Diseases, +8 more
Locations: Azienda Ospedaliera Ospedali Riuniti Villa Sofia-Cervello Palermo, PA, Italy

Policlinico Santa Maria alla Scotte Siena, SI, Italy

IRCCS Azienda Ospedaliero-Universitaria di Bologna Bologna, Italy

View Trial Details

Recruiting

Hairy Cell Leukemia: Harnessing the Full Power of Extracellular Vesicles to Improve Patient Care Management

NCT06764524

Conditions: Hairy Cell Leukemia (HCL), Hematologic Diseases, Hemic and Lymphatic Diseases, +8 more
Locations: IRCCS Azienda Ospedaliero-Universitaria di Bologna Bologna, Italy

View Trial Details

Recruiting

Therapy Optimisation for the Treatment of Hairy Cell Leukemia

NCT02131753

Conditions: Hairy Cell Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +8 more
Locations: Community based hemato-oncology medical office Ansbach, Germany

Community based hemato-oncology medical office Aschaffenburg, Germany

Rhön-Saale-Klinik gGmbH Bad Neustadt an der Saale, Germany

Community based hemato-oncology medical office Berlin, Germany

View all 76 locations

View Trial Details

Enrolling by Invitation

Rituximab+ Zanubrutinib for Patients With Hairy Cell Leukemia and Hairy Cell Variant

NCT07690761

Conditions: Hairy Cell Leukemia, Hairy Cell Leukemia Variant, Hematologic Diseases, +9 more
Locations: Bnai Zion Haifa, Israel

View Trial Details

Not Yet Recruiting

BAFF CAR-T Cells (LMY-922) for Treatment of Refractory Hematologic Malignancies

NCT07679919

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +27 more
Locations: Taussig Cancer Institute | Cleveland Clinic Cleveland, Ohio, United States

View Trial Details

Completed

ACP-196 (Acalabrutinib) in Combination With Pembrolizumab, for Treatment of Hematologic Malignancies

NCT02362035

Conditions: Blood Protein Disorders, Burkitt Lymphoma, CLL, +47 more
Locations: Research Site Tucson, Arizona, United States

Research Site Los Angeles, California, United States

Research Site Denver, Colorado, United States

Research Site Washington D.C., District of Columbia, United States

View all 19 locations

View Trial Details

Completed

Low Dose Vemurafenib and Rituximab in Hairy Cell Leukemia

NCT05388123

Conditions: Hairy Cell Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +8 more
Locations: Scripps Cancer Center La Jolla, California, United States

View Trial Details

Leukemia, Hairy Cell

Leukemia, Hairy Cell trial results

Related conditions